Alice Maiocchi , Martina Pedrini , Veronica Ferrari , Agata Sofia Assunçao Carreira , Vincenzo Maria D'Amore , Federica Santoro , Anna Di Porzio , Maddalena Bosetti , Riccardo Cristofani , Alessandra Silvani , Diego Brancaccio , Luciana Marinelli , Francesco Saverio Di Leva , Alessandro Provenzani , Angelo Poletti , Pierfausto Seneci
{"title":"作为C9orf72 G4C2延伸重复序列RNA结合物的芳基双鸟酰腙的设计、合成和表征","authors":"Alice Maiocchi , Martina Pedrini , Veronica Ferrari , Agata Sofia Assunçao Carreira , Vincenzo Maria D'Amore , Federica Santoro , Anna Di Porzio , Maddalena Bosetti , Riccardo Cristofani , Alessandra Silvani , Diego Brancaccio , Luciana Marinelli , Francesco Saverio Di Leva , Alessandro Provenzani , Angelo Poletti , Pierfausto Seneci","doi":"10.1016/j.ejmech.2025.117736","DOIUrl":null,"url":null,"abstract":"<div><div>Expanded G<sub>4</sub>C<sub>2</sub> repeats derived from mutations of the <em>C9orf72</em> gene are causative factors in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, leading to multiple pathological events. Bis thiophene <em>para</em> dinicotinimidamide <strong>2a</strong> was reported to preferentially stabilize G-quadruplex G<sub>4</sub>C<sub>2</sub> RNA structures at sub-micromolar concentrations. We replaced its amidine groups with BBB-compliant guanyl hydrazones, and carried out scaffold variations to improve water solubility. An eight-membered array was built around bis-thiophene- (<strong>4b</strong>-<strong>6a</strong>), bis-oxazole- (<strong>7b</strong>), diphenylurea diamide- (<strong>8b</strong>) and phenyldioxy ditriazolephenyl scaffolds (<strong>9a,b</strong>). Biological profiling of the array identified <strong>4b</strong> as a promising, drug-like hit, active in cellular assays on ALS patient-derived cells.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"293 ","pages":"Article 117736"},"PeriodicalIF":6.0000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats\",\"authors\":\"Alice Maiocchi , Martina Pedrini , Veronica Ferrari , Agata Sofia Assunçao Carreira , Vincenzo Maria D'Amore , Federica Santoro , Anna Di Porzio , Maddalena Bosetti , Riccardo Cristofani , Alessandra Silvani , Diego Brancaccio , Luciana Marinelli , Francesco Saverio Di Leva , Alessandro Provenzani , Angelo Poletti , Pierfausto Seneci\",\"doi\":\"10.1016/j.ejmech.2025.117736\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Expanded G<sub>4</sub>C<sub>2</sub> repeats derived from mutations of the <em>C9orf72</em> gene are causative factors in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, leading to multiple pathological events. Bis thiophene <em>para</em> dinicotinimidamide <strong>2a</strong> was reported to preferentially stabilize G-quadruplex G<sub>4</sub>C<sub>2</sub> RNA structures at sub-micromolar concentrations. We replaced its amidine groups with BBB-compliant guanyl hydrazones, and carried out scaffold variations to improve water solubility. An eight-membered array was built around bis-thiophene- (<strong>4b</strong>-<strong>6a</strong>), bis-oxazole- (<strong>7b</strong>), diphenylurea diamide- (<strong>8b</strong>) and phenyldioxy ditriazolephenyl scaffolds (<strong>9a,b</strong>). Biological profiling of the array identified <strong>4b</strong> as a promising, drug-like hit, active in cellular assays on ALS patient-derived cells.</div></div>\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"293 \",\"pages\":\"Article 117736\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S022352342500501X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S022352342500501X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats
Expanded G4C2 repeats derived from mutations of the C9orf72 gene are causative factors in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, leading to multiple pathological events. Bis thiophene para dinicotinimidamide 2a was reported to preferentially stabilize G-quadruplex G4C2 RNA structures at sub-micromolar concentrations. We replaced its amidine groups with BBB-compliant guanyl hydrazones, and carried out scaffold variations to improve water solubility. An eight-membered array was built around bis-thiophene- (4b-6a), bis-oxazole- (7b), diphenylurea diamide- (8b) and phenyldioxy ditriazolephenyl scaffolds (9a,b). Biological profiling of the array identified 4b as a promising, drug-like hit, active in cellular assays on ALS patient-derived cells.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.